drugset / Trial / NCT01751282

Study of the Effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells in Fibrin to Treat Chronic Wounds

NCT01751282

Phase 1 Terminated 5 enrolled Roger Williams Medical Center
RandomizedSingle-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the effectiveness of Autologous Bone Marrow-Derived Mesenchymal Stem Cells (MSCs) in the treatment of non-healing wounds.

Timeline

Start
2010-06
Primary completion
2015-06
Completion
2015-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous bone marrow-derived mesenchymal stem cells Cell therapy

Indications